Edith Rodríguez-Braun

881 total citations
21 papers, 478 citations indexed

About

Edith Rodríguez-Braun is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Edith Rodríguez-Braun has authored 21 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Edith Rodríguez-Braun's work include Colorectal Cancer Treatments and Studies (12 papers), Genetic factors in colorectal cancer (7 papers) and Microtubule and mitosis dynamics (5 papers). Edith Rodríguez-Braun is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Genetic factors in colorectal cancer (7 papers) and Microtubule and mitosis dynamics (5 papers). Edith Rodríguez-Braun collaborates with scholars based in Spain, United States and Finland. Edith Rodríguez-Braun's co-authors include Andrés Cervantes, Susana Roselló, Josep Tabernero, Teresa Macarulla, Pablo Conesa‐Zamora, José García‐Solano, José Baselga, Isabel Chirivella, Javier Trujillo‐Santos and Miguel Pérez‐Guillermo and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.

In The Last Decade

Edith Rodríguez-Braun

20 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edith Rodríguez-Braun Spain	11	331	157	154	105	86	21	478
Susanne Hedbom Germany	4	277 0.8×	167 1.1×	120 0.8×	119 1.1×	47 0.5×	5	463
Shinji Nakamichi Japan	13	281 0.8×	238 1.5×	268 1.7×	55 0.5×	82 1.0×	51	566
Israel Cañadas Spain	9	289 0.9×	183 1.2×	211 1.4×	16 0.2×	68 0.8×	11	487
W Zhang United States	12	367 1.1×	304 1.9×	115 0.7×	42 0.4×	119 1.4×	21	608
James Christensen United States	4	137 0.4×	245 1.6×	103 0.7×	24 0.2×	70 0.8×	8	453
Tao Osgood United States	6	185 0.6×	158 1.0×	58 0.4×	33 0.3×	32 0.4×	14	308
T. Christopher Windham United States	7	177 0.5×	203 1.3×	110 0.7×	69 0.7×	61 0.7×	14	438
Takaaki Imamura Japan	12	181 0.5×	351 2.2×	73 0.5×	23 0.2×	75 0.9×	24	647
Masaru Jida Japan	7	251 0.8×	272 1.7×	271 1.8×	27 0.3×	34 0.4×	14	469
Manali Rupji United States	13	165 0.5×	186 1.2×	111 0.7×	33 0.3×	43 0.5×	45	479

Countries citing papers authored by Edith Rodríguez-Braun

Since Specialization

Citations

This map shows the geographic impact of Edith Rodríguez-Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Rodríguez-Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Rodríguez-Braun more than expected).

Fields of papers citing papers by Edith Rodríguez-Braun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edith Rodríguez-Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Rodríguez-Braun. The network helps show where Edith Rodríguez-Braun may publish in the future.

Co-authorship network of co-authors of Edith Rodríguez-Braun

This figure shows the co-authorship network connecting the top 25 collaborators of Edith Rodríguez-Braun. A scholar is included among the top collaborators of Edith Rodríguez-Braun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edith Rodríguez-Braun. Edith Rodríguez-Braun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

García‐Rodríguez, José, Rikke Borg, Edith Rodríguez-Braun, et al.. (2025). Clinical and immunopathological evaluation and its comparison with IHC consensus molecular subtypes of colorectal cancer. Scientific Reports. 15(1). 21626–21626.

Rodríguez-Braun, Edith, et al.. (2023). Effects of imipramine on cancer patients over-expressing Fascin1; description of the HITCLIF clinical trial. Frontiers in Oncology. 13. 1238464–1238464. 5 indexed citations

Pérez-Sánz, Fernando, José García‐Solano, Patricia Sebastián-León, et al.. (2021). Global Methylome Scores Correlate with Histological Subtypes of Colorectal Carcinoma and Show Different Associations with Common Clinical and Molecular Features. Cancers. 13(20). 5165–5165. 2 indexed citations

Pérez-Sánz, Fernando, José García‐Solano, Jesualdo Tomás Fernández‐Breis, et al.. (2019). ColPortal, an integrative multiomic platform for analysing epigenetic interactions in colorectal cancer. Scientific Data. 6(1). 255–255. 12 indexed citations

García‐Solano, José, Pablo Conesa‐Zamora, Pablo Carbonell, et al.. (2012). Microsatellite pathologic score does not efficiently identify high microsatellite instability in colorectal serrated adenocarcinoma. Human Pathology. 44(5). 759–765. 4 indexed citations

Conesa‐Zamora, Pablo, José García‐Solano, Francisco García‐García, et al.. (2012). Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma. International Journal of Cancer. 132(2). 297–307. 38 indexed citations

García‐Solano, José, Pablo Conesa‐Zamora, Pablo Carbonell, et al.. (2012). Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI‐H carcinomas. International Journal of Cancer. 131(8). 1790–1799. 40 indexed citations

Macarulla, Teresa, Andrés Cervantes, Élena Elez, et al.. (2010). Phase I Study of the Selective Aurora A Kinase Inhibitor MLN8054 in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Pharmacodynamics. Molecular Cancer Therapeutics. 9(10). 2844–2852. 73 indexed citations

Tabernero, Josep, Fortunato Ciardiello, Fernando Rivera, et al.. (2009). Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study. Annals of Oncology. 21(7). 1537–1545. 72 indexed citations

10.

Macarulla, Teresa, Edith Rodríguez-Braun, Josep Tabernero, et al.. (2009). Phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of the selective aurora A kinase (AAK) inhibitor MLN8054 in patients (pts) with advanced solid tumors. Journal of Clinical Oncology. 27(15_suppl). 2578–2578. 6 indexed citations

11.

Fidalgo, José Alejandro Pérez, Desamparados Roda, Susana Roselló, Edith Rodríguez-Braun, & Andrés Cervantes. (2009). Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system. Clinical & Translational Oncology. 11(12). 787–798. 34 indexed citations

12.

Cervantes, Andrés, et al.. (2008). The treatment of advanced gastric cancer: current strategies and future perspectives. Annals of Oncology. 19. v103–v107. 72 indexed citations

13.

Cervantes, Andrés, Susana Roselló, Edith Rodríguez-Braun, et al.. (2008). Progress in the multidisciplinary treatment of gastrointestinal cancer and the impact on clinical practice: perioperative management of rectal cancer. Annals of Oncology. 19. vii266–vii272. 10 indexed citations

14.

Cervantes, Andrés, Teresa Macarulla, Susana Roselló, et al.. (2008). 279 POSTER MLN8054, a selective inhibitor of Aurora A kinase: final results of a phase I clinical trial. European Journal of Cancer Supplements. 6(12). 90–90. 4 indexed citations

15.

Martín-Martorell, Paloma, Susana Roselló, Edith Rodríguez-Braun, et al.. (2008). Biweekly cetuximab and irinotecan in advanced colorectal cancer patients progressing after at least one previous line of chemotherapy: results of a phase II single institution trial. British Journal of Cancer. 99(3). 455–458. 47 indexed citations

16.

Cervantes, Andrés, Élena Elez, Teresa Macarulla, et al.. (2008). 285 POSTER MLN8237, an oral selective Aurora A kinase inhibitor: initial results of dose-finding pharmacokinetic-pharmacodynamic phase I study. European Journal of Cancer Supplements. 6(12). 92–92. 3 indexed citations

17.

Cervantes, Andrés, Teresa Macarulla, Erika Martinelli, et al.. (2008). Correlation of KRAS status (wild type [wt] vs. mutant [mt]) with efficacy to first-line cetuximab in a study of cetuximab single agent followed by cetuximab + FOLFIRI in patients (pts) with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 26(15_suppl). 4129–4129. 17 indexed citations

18.

Cervantes, Andrés, et al.. (2007). Integrative decisions in rectal cancer. Annals of Oncology. 18. ix127–ix131. 10 indexed citations

19.

Ciardiello, Fortunato, Andrés Cervantes, M. E. Vega-Villegas, et al.. (2007). 3040 POSTER Optimal dose for an every 2 week (q2w) cetuximab (C) regimen in patients (pts) with metastatic colorectal cancer (mCRC): a phase I safety, pharmacokinetics (PK) and pharmacodynamics (PD) study of weekly (q1w) and q2w schedules. European Journal of Cancer Supplements. 5(4). 247–247. 4 indexed citations

20.

Cervantes, Andrés, et al.. (2006). A multimodality approach to localized rectal cancer. Annals of Oncology. 17. x129–x134. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact